Ceramic-reinforced HEA matrix composites exhibiting an excellent combination of mechanical properties.

CoCrFeNi is a well-studied face centered cubic (fcc) high entropy alloy (HEA) that exhibits excellent ductility but only limited strength. The present study focusses on improving the strength-ductility balance of this HEA by addition of varying amounts of SiC using an arc melting route. Chromium present in the base HEA is found to result in decomposition of SiC during melting. Consequently, interaction of free carbon with chromium results in the in-situ formation of chromium carbide, while free silicon remains in solution in the base HEA and/or interacts with the constituent elements of the base HEA to form silicides. The changes in microstructural phases with increasing amount of SiC are found to follow the sequence: fcc → fcc + eutectic → fcc + chromium carbide platelets → fcc + chromium carbide platelets + silicides → fcc + chromium carbide platelets + silicides + graphite globules/flakes. In comparison to both conventional and high entropy alloys, the resulting composites were found to exhibit a very wide range of mechanical properties (yield strength from 277 MPa with more than 60% elongation to 2522 MPa with 6% elongation). Some of the developed high entropy composites showed an outstanding combination of mechanical properties (yield strength 1200 MPa with 37% elongation) and occupied previously unattainable regions in a yield strength versus elongation map. In addition to their significant elongation, the hardness and yield strength of the HEA composites are found to lie in the same range as those of bulk metallic glasses. It is therefore believed that development of high entropy composites can help in obtaining outstanding combinations of mechanical properties for advanced structural applications.

Role of dietary magnesium and/or manganese variables on Ehrlich ascites tumor-bearing mice.

Female Swiss albino mice were placed on seven dietary regimens for five weeks. These regimens differed only in magnesium and/or manganese contents. At the end of the feeding period, the animals were inoculated with Ehrlich ascites tumor. Ten days after transplantation, Ehrlich ascites carcinoma (EAC) cells were harvested, and all animals were killed. EAC cells and plasma samples were subjected to several biochemical tests. The results suggest several conclusions. 1. Dietary supplements of magnesium and/or manganese have no effect on retarding tumor growth in vivo. 2. Dietary restriction of manganese and combined magnesium and manganese gave promising effects on retarding tumor growth in vivo. 3. Dietary magnesium deficiency, per se, had no significant effect on tumor regression in vivo. 4. In contrast to in vitro studies, manganese supplementation appeared to exert no effect on tumor progression in vivo. 5. Magnesium supplementation seemed to have no effect on tumor progression in vivo, which is in agreement with in vitro studies.